Clinical trial
Special Drug Use-results Survey for Long-term Use (Fostamatinib)
NCT06757257 is registered in ClinicalTrials.gov with Kissei Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Special Drug Use-results Survey for Long-term Use (Fostamatinib)
- Lead sponsor
- Kissei Pharmaceutical Co., Ltd.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 29, 2023
- Completion date
- September 30, 2028
- Enrollment
- 149 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic idiopathic thrombocytopenic purpura